Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-031626
Filing Date
2026-05-07
Accepted
2026-05-07 06:09:56
Documents
80
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zlab-20260331.htm   iXBRL 10-Q 891481
2 EX-31.1 zlab-20260331x10qxexx311.htm EX-31.1 8196
3 EX-31.2 zlab-20260331x10qxexx312.htm EX-31.2 8205
4 EX-32.1 zlab-20260331x10qxexx321.htm EX-32.1 4679
5 EX-32.2 zlab-20260331x10qxexx322.htm EX-32.2 4737
11 zlab-20260331_g1.jpg GRAPHIC 14140
  Complete submission text file 0001628280-26-031626.txt   5306532

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20260331.xsd EX-101.SCH 45974
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zlab-20260331_cal.xml EX-101.CAL 74338
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20260331_def.xml EX-101.DEF 160246
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20260331_lab.xml EX-101.LAB 556172
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20260331_pre.xml EX-101.PRE 362759
84 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20260331_htm.xml XML 545758
Mailing Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China
Business Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38205 | Film No.: 26950625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)